Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002842 · ClinicalTrials.gov registry record · Phase 2
Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase 2 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00002842 is a Phase 2 study that has completed, run by City of Hope Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT00002842, a Phase 2 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of surgery followed by floxuridine plus systemic fluorouracil and leucovorin in treating patients with liver metastases from colorectal cancer.
Interventions
- DRUG fluorouracil
- DRUG leucovorin calcium
- PROCEDURE conventional surgery
- PROCEDURE adjuvant therapy
- DRUG floxuridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 1994-09 |
| Est. Completion | 2014-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002842
The ClinicalTrials.gov registry entry for NCT00002842 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which fluorouracil is the first listed.
NCT00002842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002842 about?
NCT00002842 is a clinical study titled "Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of surgery followed by floxuridine pl...
What is the current status of trial NCT00002842?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 1994-09. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00002842?
The interventions under investigation include: fluorouracil (DRUG), leucovorin calcium (DRUG), conventional surgery (PROCEDURE), adjuvant therapy (PROCEDURE), floxuridine (DRUG).
Who is sponsoring clinical trial NCT00002842?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.